References
- Afelt, A., R. Frutos, and C. Devaux. 2018. “Bats, Coronaviruses, and Deforestation: Toward the Emergence of Novel Infectious Diseases?” Frontiers in Microbiology 9 (April): 702. http://doi.org/10.3389/fmicb.2018.00702
- Ansede, M. 2020. “Hallados ‘cientos’ de nuevos coronavirus en murciélagos de China” [“Hundreds” of New Coronvirus Discovered in Bats in China]. EL PAÍS, June 4, sec. Ciencia. https://elpais.com/ciencia/2020-06-04/hallados-cientos-de-nuevos-coronavirus-en-murcielagos-de-china.html.
- Bentley, L. 2017. “Why Vaccine Manufacturers Are Exempt from Liability.” Sonoran News, July 3. http://sonorannews.com/2017/07/03/vaccine-manufacturers-exempt-liability/.
- Bleich, S., J. Cohen, B. Sommers, and J. Allen. 2020. “Why Partisan Politics Keeps 14 Million Hungry Children from Getting the Food They Need.” USA Today, October 28. https://www.usatoday.com/story/opinion/2020/10/28/how-politics-keeps-14-million-american-kids-getting-enough-food-column/6051427002/.
- Boulware, D. R., M. F. Pullen, A. S. Bangdiwala, K. A. Pastick, S. M. Lofgren, E. C. Okafor, C. P. Skipper, et al. 2020. “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.” New England Journal of Medicine 383 (6): 517–525.
- Brading, T. 2020. “Army Targets COVID-19 Vaccine by End of Year, Human Testing in Summer.” Defense News, June 3. US Department of Defense. https://www.defense.gov/Explore/News/Article/Article/2204940/army-targets-covid-19-vaccine-by-end-of-year-human-testing-in-summer/.
- Carbajal, B. 2020. “La Jornada: Expectativa de vacuna dispara el valor de empresas farmacéuticas” [La Jornada: Anticipations of a Vaccine Shoot-Up the Value of Pharmaceutical Companies Stock Shares]. https://www.jornada.com.mx/2020/07/31/economia/021n1eco.
- Carrington, D. 2020. “Pandemics Result from Destruction of Nature, Say UN and WHO.” The Guardian, June 17, World News Section. https://www.theguardian.com/world/2020/jun/17/pandemics-destruction-nature-un-who-legislation-trade-green-recovery.
- CDC [Centers for Disease Control] and Prevention. 2020. “Coronavirus Disease 2019 (COVID-19)—Symptoms.” Centers for Disease Control and Prevention, USA. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
- Cheng, V. C. C., S. K. P. Lau, P. C. Y. Woo, and K. Yuen. 2007. “Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection.” Clinical Microbiology Reviews 20 (4): 660–694.
- Cohen, R. M. 2020. “To Develop a Covid-19 Vaccine, Pharma and the Federal Government Will Have to Break Old Patterns.” The Intercept. https://theintercept.com/2020/03/27/us-government-vaccines-big-pharma/.
- Coleman, J. 2020. “US Intelligence Warned in November That Coronavirus Spreading in China Could Be ‘Cataclysmic Event’: Report.” The Hill. https://thehill.com/policy/national-security/intelligence/491712-us-intelligence-warned-in-november-that-virus-spreading.
- Crescent, M., C. M. Hales, Q. Gu, and C. L. Ogden. 2019. “Prescription Drug Use in the United States, 2015–2016.” NCHS Data Brief, no. 334. https://www.cdc.gov/nchs/products/databriefs/db334.htm.
- Davey, M., S. Kirchgaessner, and S. Boseley. 2020. “Surgisphere: Governments and WHO Changed Covid-19 Policy Based on Suspect Data from Tiny US Company.” Defend Democracy Press, June 3. http://www.defenddemocracy.press/surgisphere-governments-and-who-changed-covid-19-policy-based-on-suspect-data-from-tiny-us-company/.
- De Klerk, G. J. M. 1979. “Mechanism and Vitalism: A History of the Controversy.” Acta Biotheoretica 28 (1): 1–10.
- Deutscher Bundestag. 2013. “Bericht Zur Risikoanalyse Im Bevölkerungsschutz 2012” [Report on Risk Analysis in Civil Protection 2012]. Drucksache 17/12051. https://www.bbk.bund.de/SharedDocs/Downloads/BBK/DE/Downloads/Krisenmanagement/BT-Bericht_Risikoanalyse_im_BevSch_2012.pdf?__blob=publicationFile.
- Dunbar-Ortiz, R. 2014. An Indigenous Peoples’ History of the United States. Boston: Beacon Press.
- Escobar, P. 2020. “China Locked in Hybrid War with US.” Asia Times. https://asiatimes.com/2020/03/china-locked-in-hybrid-war-with-us/.
- Farmer, P. 1996. “Social Inequalities and Emerging Infectious Diseases.” Emerging Infectious Diseases 2 (4): 259–269.
- Federspil, G., and N. Sicolob. 1994. “The Nature of Life in the History of Medical and Philosophic Thinking.” American Journal of Nephrology 14 (4–6): 337–343.
- Foladori, G., and R. Delgado Wise. 2020. “Para Comprender El Impacto Disruptivo Del Covid-19, Un Análisis Desde La Crítica de La Economía Política” [Understanding the Disruptive Impact of Covid-19: A Critical Political Economy Analysis]. Migración y Desarrollo 18 (34): 161–178.
- Fugh-Berman, A. J. 2010. “The Haunting of Medical Journals: How Ghostwriting Sold ‘HRT’.” PLoS Medicine (Public Library of Science Medicine) 7 (9): e1000335.
- Geleris, J., Y. Sun, J. Platt, J. Zucker, M. Baldwin, G. Hripcsak, A. Labella, et al. 2020. “Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.” New England Journal of Medicine 382 (25): 2411–2418.
- Grabowski, H. G., and J. M. Vernon. 1994. “Returns to R&D on New Drug Introductions in the 1980s.” Journal of Health Economics 13 (4): 383–406.
- Grady, D. 2019. “Deadly Germ Research Is Shut Down at Army Lab over Safety Concerns.” New York Times, August 5, sec. Health. https://www.nytimes.com/2019/08/05/health/germs-fort-detrick-biohazard.html.
- Hahnemann, S. 2007. The Chronic Diseases: Their Peculiar Nature and Their Homeopathic Cure, vol. 1. Noida: B Jain.
- Heather, M. 2019. “CDC Inspection Findings Reveal More about USAMRIID Research Suspension.” The Frederick News-Post. https://www.fredericknewspost.com/news/politics_and_government/military/cdc-inspection-findings-reveal-more-about-usamriid-research-suspension/article_6d1d316e-4989-5307-924c-8608c25ef6f7.html.
- Hodgson, J. 2020. “The Pandemic Pipeline.” Nature Biotechnology 38 (5): 523–532.
- Holland, M. S. 2017. “Liability for Vaccine Injury: The United States, the European Union and the Developing World.” Emory Law Journal 67 (3): 415–462.
- Institute of Medicine. 2003. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press.
- International Crisis Group. 2020. “COVID-19 and Conflict: Seven Trends to Watch.” Crisis Group Special Briefing, March 24. https://www.crisisgroup.org/global/sb4-covid-19-and-conflict-seven-trends-watch.
- Jouanna, J. 2012. Greek Medicine from Hippocrates to Galen: Selected Papers. Leiden/Boston: Brill.
- Kels, C. G. 2015. “Dispensing Medical Countermeasures: Emergency Use Authorities and Liability Protections.” Health Security 13 (2): 139–151.
- Kime, P. 2020. “US Troops Would Be Among First to Get a Working COVID-19 Vaccine, Officials Say.” Military.Com, June 16. https://www.military.com/daily-news/2020/06/16/us-troops-would-be-among-first-get-working-covid-19-vaccine-officials-say.html.
- Kirchhelle, C. 2018. “Pharming Animals: A Global History of Antibiotics in Food Production (1935–2017).” Palgrave Communications 4 (1): 1–13.
- Kumar, A., A. Tan, J. Wong, J. C. Spagnoli, J. Lam, B. D. Blevins, G. Natasha, et al. 2017. “Nanotechnology for Neuroscience: Promising Approaches for Diagnostics, Therapeutics and Brain Activity Mapping.” Advanced Functional Materials 27 (39): 1–60.
- Lewis, R. 2016. “Does Chinese Civilization Come from Ancient Egypt?” Foreign Policy, September 2. https://foreignpolicy.com/2016/09/02/did-chinese-civilization-come-from-ancient-egypt-archeological-debate-at-heart-of-china-national-identity/.
- Lee, D. Y. W., Q. Y. Li, J. Liu, and T. Efferth. 2021. “Traditional Chinese Herbal Medicine at the Forefront Battle against COVID-19: Clinical Experience and Scientific Basis.” Phytomedicine 80 (January): 153337. doi:10.1016/j.phymed.2020.153337.
- Lovells, H. 2020. “Navigating Limits on Product Liability under the PREP Act for COVID-19 Clinical Trial Activities.” Hogan Lovells Publications, March 23. http://www.hoganlovells.com/en/publications/navigating-limits-on-product-liability-under-the-prep-act-for-covid-19-clinical-trial-activities.
- Luo, E., D. Zhang, H. Luo, B. Liu, K. Zhao, Y. Zhao, Y. Bian, and Y. Wang. 2020. “Treatment Efficacy Analysis of Traditional Chinese Medicine for Novel Coronavirus Pneumonia (COVID-19): An Empirical Study from Wuhan, Hubei Province, China.” Chinese Medicine 15 (April): 34. doi:10.1186/s13020-020-00317-x.
- Marcum, J. A. 2008. An Introductory Philosophy of Medicine: Humanizing Modern Medicine. Dordrecht: Springer.
- Mariappan, N. 2019. “Recent Trends in Nanotechnology Applications in Surgical Specialties and Orthopedic Surgery.” Biomedical and Pharmacology Journal 12 (3): 1095–1127.
- Martinez, L. 2020. “Study of Young Marines in Basic Training Could Provide Coronavirus Clues.” abc7 New York, July 29. https://abc7ny.com/6338681/.
- Moderna. 2013. “DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics™.” https://investors.modernatx.com/news-releases/news-release-details/darpa-awards-moderna-therapeutics-grant-25-million-develop/.
- Moritz, S. 2016. “Alchemy and Contemporary Spagyric Medicine: A Historical, Medical and Socio-Scientific Approach.” Interdisciplinary Science Reviews 41 (1): 13–27.
- Mustasilta, K. 2020. “From Bad to Worse? The Impact(s) of Covid-19 on Conflict Dynamics.” European Union Institute for Security Studies. https://www.iss.europa.eu/content/bad-worse-impacts-covid-19-conflict-dynamics.
- Nayak, D., and R. Varanasi. 2020. “Homoeopathic Nosodes, a Neglected Approach for Epidemics: A Critical Review.” Indian Journal of Research in Homoeopathy 14 (2): 129–135.
- NIAD (National Institute of Allergy and Infectious Diseases). 2000. “Fact Sheet. Antimicrobial Resistance.” National Institute of Allergy and Infectious Diseases, USA. www.niaid.nih.gov/factsheets/antimicro.htm.
- O’Connor, T., J. Fink, and N. Jamali. 2020. “Late US Intelligence Alerts, Slow Pentagon Response, Contributed to US Military’s COVID-19 Outbreak, Documents Show.” Newsweek, April 14. https://www.newsweek.com/late-us-intelligence-community-alerts-slow-pentagon-response-contributed-us-militarys-1497620.
- OPS (Pan American Health Organization). 2020. “Uso de la Medicina Natural y Tradicional Como Herramienta Para el Enfrentamiento a la COVID-19” [The Use of Natural and Traditional Medicine as a Tool to Confront COVID-19]. Andar La Salud 24 (2): 25–27.
- Peters, A. 2018. “The Global Proliferation of High-Containment Biological Laboratories: Understanding the Phenomenon and Its Implications.” Revue Scientifique et Technique de l'OIE 37 (3): 857–883.
- Plotkin, S. A., W. A. Orenstein, and P. A. Offit. 2018. Plotkin’s Vaccines. 7th ed. Philadelphia, PA: Elsevier.
- Podolsky, S. H. 2018. “The Evolving Response to Antibiotic Resistance (1945–2018).” Palgrave Communications 4 (1): 1–8.
- Powell, T. 2017a. “Biological Warfare in the Korean War: Allegations and Cover-Up.” Socialism and Democracy 31 (1): 23–42.
- Powell, T. 2017b. “Korean War Biological Warfare Update.” Socialism and Democracy 31 (3): 123–137.
- Powell, T. 2018. “On the Biological Warfare ‘Hoax’ Thesis.” Socialism and Democracy 32 (1): 1–22.
- Powell, T. 2019. “Biological Warfare in Korea: A Review of the Literature.” Socialism and Democracy 33 (2): 67–107.
- Rasel, N.-E.-A., M. R. Siddique, R. A. Rume, and A. K. Azad. 2020. “Covid-19: A Homeopathic Recommendation to Global Health Policy.” International Journal of Homoeopathic Sciences 4 (3): 1–5.
- Ren, W., P. Liang, Y. Ma, Q. Sun, Q. Pu, L. Dong, G. Luo, et al. 2021. “Research Progress of Traditional Chinese Medicine against COVID-19.” Biomedicine & Pharmacotherapy 137 (May): 111310. doi:10.1016/j.biopha.2021.111310.
- Rome, B. N., and J. Avorn. 2020. “Drug Evaluation during the Covid-19 Pandemic.” New England Journal of Medicine 382 (24): 2282–2284.
- Saratchand, C., and N. Kaur. 2020. “On Hegemonic Narratives, and the Facts regarding China’s Response to COVID-19 Pandemic.” International Critical Thought 10 (4): 575–604.
- Shankar, A., A. Dubey, D. Saini, and C. P. Prasad. 2020. “Role of Complementary and Alternative Medicine in Prevention and Treatment of COVID-19: An Overhyped Hope.” Chinese Journal of Integrative Medicine 26 (8): 565–567.
- Shin, M. D., S. Shukla, Y. Chung, V. Beiss, S. Chan, O. A. Ortega-Rivera, D. M. Wirth, et al. 2020. “COVID-19 Vaccine Development and a Potential Nanomaterial Path Forward.” Nature Nanotechnology 15 (8): 646–655.
- Smith, R. 2005. “Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies.” PLOS Medicine 2 (5): e138.
- Stone, I. F. 1971. The Hidden History of the Korean War. New York: Monthly Review Press.
- Stoykova, Z., and L. Koeva-Dimitrova. 2019. “Personalized Medicine from Ancient Times to the Present.” [In Russian.] Health Economics and Management 1 (71): 10–20.
- Subbarayappa, B. V. 2001. “The Roots of Ancient Medicine: An Historical Outline.” Journal of Biosciences 26 (2): 135–143. doi:10.1007/bf02703637.
- Ulrich, L. 2020. “Isn’t It a Good Time to Be in the Open Air?” New York Times, July 24.
- US Department of Health & Human Services. 2019. “PREP Act Q&As.” Public Health Emergency. https://www.phe.gov/Preparedness/legal/prepact/Pages/prepqa.aspx.
- Van, T. T. H., Z. Yidana, P. M. Smooker, and P. J. Coloe. 2020. “Antibiotic Use in Food Animals Worldwide, with a Focus on Africa: Pluses and Minuses.” Journal of Global Antimicrobial Resistance 20 (March): 170–177.
- Varghese, T. M., O. Sivaraman Nirmal Ghosh, D. Bijukumar, K. C. Muraleedharan, and S. G. Biju. 2020. “Efficacy of Arsenicum Alb 30C for Upregulating Immunological Markers among Residents of COVID-19 Related Hot Spot Areas in Pathanamthitta, Kerala.”. https://doi.org/10.13140/RG.2.2.26387.71200
- Vellingiri, B., K. Jayaramayya, M. Iyer, A. Narayanasamy, V. Govindasamy, B. Giridharan, S. Ganesan, et al. 2020. “COVID-19: A Promising Cure for the Global Panic.” Science of the Total Environment 725 (July): 138–277.
- Wang, Y., D. Zhang, G. Du, R. Du, J. Zhao, Y. Jin, S. Fu, et al. 2020. “Remdesivir in Adults with Severe COVID-19: A Randomised, Double-Blind, Placebo-Controlled, Multicentre Trial.” The Lancet 395 (10236): 1569–1578.
- Wise, R., T. Hart, O. Cars, M. Streulens, R. Helmuth, P. Huovinen, and M. Sprenger. 1998. “Antimicrobial Resistance.” BMJ 317 (7159): 609–610.
- World Health Organization. 2020. “COVID-19 Situation Reports.” Coronavirus Disease. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4.
- Zhang, Y., and Y. Wu. 2020. “TCM Provides Path to Higher Recovery Rate.” China Daily, March 16 https://www.chinadailyhk.com/article/124480#TCM-provides-path-to-higher-recovery-rate.